1. Home
  2. MRNS vs PMNT Comparison

MRNS vs PMNT Comparison

Compare MRNS & PMNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRNS
  • PMNT
  • Stock Information
  • Founded
  • MRNS 2003
  • PMNT 1984
  • Country
  • MRNS United States
  • PMNT United Kingdom
  • Employees
  • MRNS N/A
  • PMNT N/A
  • Industry
  • MRNS Biotechnology: Pharmaceutical Preparations
  • PMNT
  • Sector
  • MRNS Health Care
  • PMNT
  • Exchange
  • MRNS Nasdaq
  • PMNT NYSE
  • Market Cap
  • MRNS 19.0M
  • PMNT 15.9M
  • IPO Year
  • MRNS 2014
  • PMNT 2024
  • Fundamental
  • Price
  • MRNS $0.30
  • PMNT $0.83
  • Analyst Decision
  • MRNS Buy
  • PMNT Strong Buy
  • Analyst Count
  • MRNS 12
  • PMNT 1
  • Target Price
  • MRNS $4.28
  • PMNT $6.00
  • AVG Volume (30 Days)
  • MRNS 6.6M
  • PMNT 23.3K
  • Earning Date
  • MRNS 11-12-2024
  • PMNT 11-14-2024
  • Dividend Yield
  • MRNS N/A
  • PMNT N/A
  • EPS Growth
  • MRNS N/A
  • PMNT N/A
  • EPS
  • MRNS N/A
  • PMNT N/A
  • Revenue
  • MRNS $31,466,000.00
  • PMNT $22,375,000.00
  • Revenue This Year
  • MRNS $20.74
  • PMNT $3.91
  • Revenue Next Year
  • MRNS $32.38
  • PMNT $29.32
  • P/E Ratio
  • MRNS N/A
  • PMNT N/A
  • Revenue Growth
  • MRNS 1.63
  • PMNT N/A
  • 52 Week Low
  • MRNS $0.26
  • PMNT $0.83
  • 52 Week High
  • MRNS $11.26
  • PMNT $6.05
  • Technical
  • Relative Strength Index (RSI)
  • MRNS 25.07
  • PMNT N/A
  • Support Level
  • MRNS $0.29
  • PMNT N/A
  • Resistance Level
  • MRNS $0.37
  • PMNT N/A
  • Average True Range (ATR)
  • MRNS 0.04
  • PMNT 0.00
  • MACD
  • MRNS 0.02
  • PMNT 0.00
  • Stochastic Oscillator
  • MRNS 17.95
  • PMNT 0.00

About MRNS Marinus Pharmaceuticals Inc.

Marinus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing innovative therapeutics to treat epilepsy and neuropsychiatric disorders. Marinus manages the business in one segment, which is the identification and development of neuropsychiatric therapeutics. The Company is developing ganaxolone for multiple epilepsy and other neuropsychiatric indications, including adjunctive, or add-on, therapy for the treatment of drug-resistant focal onset seizures; status epilepticus; Fragile X Syndrome, and PCDH19-RE.

About PMNT PERFECT MOMENT LTD

Perfect Moment Ltd is a company which is a luxury lifestyle brand that combines fashion and technical performance for its ranges of skiwear, outerwear, swimwear, and activewear. It operates at the intersection of luxury fashion and multi-channel commerce. Although the Company is organized fundamentally as one business segment which is product sales, the Company's revenues are primarily split between three geographic areas which are the U. S., Europe, and the UK.

Share on Social Networks: